The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Targeting The Sympathetic Nervous System To Reduce The Burden Of Fatty Liver Disease
Funder
National Health and Medical Research Council
Funding Amount
$728,152.00
Summary
The metabolic syndrome is characterised by abdominal obesity, high blood pressure and an increased risk of diabetes development. It is clear from our own observations that the sympathetic nervous system (SNS) is important in the generation of obesity-related illness and, through its stimulation of the liver, plays an important role in the development of obesity-related liver disease. We will target the SNS in order to reduce the burden of obesity-related liver disease.
Adipose Distribution, Hepatic Lipid Partitioning And Pathogenesis Of Non-alcoholic Steatohepatitis
Funder
National Health and Medical Research Council
Funding Amount
$133,601.00
Summary
The rising prevalence of obesity and diabetes has led to increase incidence of fatty liver disease and non-alcoholic steatohepatitis (NASH), a form of liver damage that can result in cirrhosis and liver cancer. Currently, approximately 30% people store fat poorly, resulting in increased waist circumference and higher risk of diabetes, cardiovascular disease and NASH. Animal studies are now underway to determine the switch which turns “good fat” to “bad fat”, to identify ways of preventing diabet ....The rising prevalence of obesity and diabetes has led to increase incidence of fatty liver disease and non-alcoholic steatohepatitis (NASH), a form of liver damage that can result in cirrhosis and liver cancer. Currently, approximately 30% people store fat poorly, resulting in increased waist circumference and higher risk of diabetes, cardiovascular disease and NASH. Animal studies are now underway to determine the switch which turns “good fat” to “bad fat”, to identify ways of preventing diabetes, NASH and other adverse outcomes of obesity.Read moreRead less
Monocytes/macrophages In Chronic Liver Diseases: Cross-talk With Hepatocytes And Nonparenchymal Cells And Role In Progressive Liver Injury
Funder
National Health and Medical Research Council
Funding Amount
$598,645.00
Summary
More than 170 million people world-wide are chronically infected with the hepatitis C virus. Approximately 10-15% of chronically infected subjects develop cirrhosis with its attendant risks of liver failure and hepatocellular carcinoma. The objective of this important project is to examine the mechanisms by which monocytes and macrophages (cells of the immune system) enhance or impair the progression of liver disease and response to antiviral treatment in patients with chronic hepatitis C.
An Objective Screening Test For Deglutitive Aspiration And Swallowing Function In Children With Dysphagia
Funder
National Health and Medical Research Council
Funding Amount
$476,641.00
Summary
Swallowing dysfunction (dysphagia) is common in children with neurological diseases such as cerebral palsy which affects 1:400 births. Fluid in the lungs during swallow (aspiration) is a serious complication causing chest infections and potentially death. We have developed a new test measuring pressures and flows during swallow which can detect abnormalities predisposing to aspiration and we will evaluate this as a screening tool.
Use Of Oral Enzymes To Treat Carbohydrate Intolerance: Adjunct Therapy To The Low FODMAP Dietary Treatment Of Irritable Bowel Syndrome.
Funder
National Health and Medical Research Council
Funding Amount
$610,197.00
Summary
Irritable bowel syndrome (IBS) is a common disorder affecting 1 in 7 Australians and fermentation of poorly digested short chain carbohydrates are major dietary triggers. The lack of certain digestive enzymes is a major reason why some carbohydrates are not digested. This project will explore the potential use of oral enzyme supplements to assist with the digestion of these indigestible carbohydrates with the potential for use as adjunct therapy to treat gut symptoms associated with IBS.
The Role Of The Adiponectin Receptors In Liver Fibrosis
Funder
National Health and Medical Research Council
Funding Amount
$393,159.00
Summary
Advanced liver scarring (fibrosis) contributes to the death of 1500 Australians annually. Two-thirds of our community is overweight or obese, and this worsens liver disease. A protein secreted by fat, adiponectin, may be important as it acts on liver cells to promote fibrosis. To understand adiponectins role, we will use mice null for adiponectin receptor genes and study its action on liver cells. This study will improve our understanding of liver scarring biology and patient treatments.
Neuroimmune Interactions In Functional And Organic Gastrointestinal Diseases
Funder
National Health and Medical Research Council
Funding Amount
$419,180.00
Summary
Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD) are chronic, incurable diseases of the lower gastrointestinal tract with unknown causes and poor treatment options. Both the immune and nervous systems are altered in GI disease, but have traditionally been studied in isolation. My research investigates how the neuro-immune axis is altered in these diseases, using animal models and human tissue samples to identify novel treatment options for these debilitating diseases.
Vagal Nerve Stimulation As A Novel Therapy In Inflammatory Bowel Disease
Funder
National Health and Medical Research Council
Funding Amount
$88,502.00
Summary
Inflammatory bowel disease (IBD) is common exerting a large personal and societal burden to the Australian population. Current medications used to treat IBD are expensive, have many side effects and at times require hospitalisation for their administration. We aim to develop the non invasive and inexpensive technique of vagal nerve stimulation as a novel treatment strategy for IBD.
The Role Of Wheat Gluten In The Genesis Of Gastrointestinal Symptoms And Fatigue In Patients With Non-coeliac Gluten Intolerance.
Funder
National Health and Medical Research Council
Funding Amount
$686,242.00
Summary
Currently �gluten- and wheat-intolerances� are poorly recognised by the medical profession and yet many Australians who do not have coeliac disease claim to be wheat- or gluten-intolerant. The most common complaints relate to chronic fatigue and gut symptoms such as wind and bloating. Our research team have new and recent evidence that wheat-gluten does trigger symptoms in some patients who suffer from Irritable Bowel Syndrome. This project aims to improve our understanding in this area.